Concepedia

Amanda Cano

AC

39

Publications

2K

Citations

25

H-Index

2016

Active since

Affiliations

Biomedical Research Networking Center on Neurodegenerative Diseases(Current)

Universitat de Barcelona

Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona

Instituto de Salud Carlos III

Universitat Internacional de Catalunya

Amanda Cano is an author at Biomedical Research Networking Center on Neurodegenerative Diseases specializing in medicine, nanomedicine, and engineering.

ORCID

Top concepts

Publications per year

2016–2025

39

Publications

39

Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model

Amanda Cano, Miren Ettcheto, Jui-Hsien Chang et al. · Journal of Controlled Release · 2019 · 315 citations · Full text

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

Elena Sánchez‐López, Miren Ettcheto, María Antonia Egea et al. · Journal of Nanobiotechnology · 2018 · 270 citations · Full text

PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen—in vitro, ex vivo and in vivo characterization

Elena Sánchez‐López, M.A. Egea, Amanda Cano et al. · Colloids and Surfaces B Biointerfaces · 2016 · 143 citations

, , +14

Current Advances in The Development of Novel Polymeric Nanoparticles for The Treatment of Neurodegenerative Diseases

Amanda Cano, Elena Sánchez‐López, Miren Ettcheto et al. · Nanomedicine · 2020 · 133 citations

Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy

Amanda Cano, Miren Ettcheto, Marta Espina et al. · Nanomedicine Nanotechnology Biology and Medicine · 2018 · 89 citations

, , +8

Rows per page

1–5 of 39